NR1H4 and hepatocellular carcinoma: In conclusion, the regulatory mechanisms of FXR and its involvement in the gut-liver axis offer significant clinical and research potential for the prevention and treatment of MASLD and HCC, particularly through multi-target therapeutic approaches.